期刊文献+

脂多糖结合蛋白、血清淀粉样蛋白A和降钙素原在自发性腹膜炎患者中的应用 被引量:3

The application of lipopolysaccharide binding protein,serum amyloid A and procalcitonin in patient with spontaneous bacterial peritonitis
原文传递
导出
摘要 目的探讨脂多糖结合蛋白(LBP)、血清淀粉样蛋白A(SAA)和降钙素原(PCT)在自发性腹膜炎(SBP)患者中的表达水平及其应用价值。方法选取2012年1月-2014年6月肝硬化腹水患者125例,分为SBP组64例,非SBP组61例。采用酶联免疫吸附法(ELISA)检测LBP,采用免疫比浊法检测SAA,采用免疫化学发光法(ILMA)测定PCT。结果 LBP、SAA和PCT在SBP组表达水平显著高于非SBP组和对照组,差异有统计学意义(P<0.05);治疗有效患者治疗前的LBP、SAA和PCT表达水平显著高于治疗后恢复期,差异有统计学意义(P<0.05);LBP、SAA和PCT在死亡组表达水平显著高于存活组,差异有统计学意义(P<0.05)。结论 SBP患者血清LBP、SAA和PCT均有较高的表达,并与疾病严重程度及预后密切相关。 Objective To study the expression level and its application value of lipopolysaccharide binding protein( LBP),serum amyloid A( SAA) and procalcitonin( PCT) in patients with spontaneous peritonitis( SBP). Methods A total of 125 patients were selected from January 2012 to June 2014,including SBP group 64 cases and non SBP group 61 cases. LBP was tested by enzyme- linked- immunosorbent( ELISA),SAA was tested by immunoturbidimetry,PCT was tested with immune chemiluminescence( ILMA). Results The levels of LBP,SAA and PCT in SBP group had a significantly higher expression than that of non SBP group and the control group( P〈 0. 05). The levels of LBP,SAA and PCT in patients with SBP group who were treated effectively before treatment had a significantly higher expression than that of recovery stage after treatment( P〈 0. 05). The levels of LBP,SAA and PCT in death group were significantly higher expression than that of the survival group( P〈 0. 05). Conclusion The expression levels of LBP,SAA and PCT in patients with SBP are significantly higher,and the change of LBP,SAA and PCT are correlated with the condition and prognosis of this disease.
出处 《中国卫生检验杂志》 CAS 2015年第21期3651-3652,共2页 Chinese Journal of Health Laboratory Technology
基金 浙江省丽水市科技局资助项目(2011-7)
关键词 脂多糖结合蛋白 血清淀粉样蛋白A 降钙素原 自发性腹膜炎 Lipopolysaccharide binding protein Serum amyloid A Procalcitonin Spontaneous peritonitis
  • 相关文献

参考文献8

二级参考文献44

  • 1朱华,王娟,林燕,张芃,刘家民.血清淀粉样蛋白A的研究进展[J].心血管病学进展,2007,28(1):113-115. 被引量:17
  • 2Becker KL,Nylen ES,White JC,et al.Procalcitonin and the calcitonin gene family of peptides in inflammation,infection,and sepsis:a journey from calcitonin back to its precursors[J].J Clin Endocrinol Metab,2004,89(4):1512-1525.
  • 3Athhan F,Akagunduz B,Genel F,et al.Procalcitonin:a marker of neonatal sepsis[J].J Trop Pediatr,2002,48(1):10-14.
  • 4Dandona P,Nix D,Wilson MF,et al.Procalcitonin increase[J].J Clin Endocrinol Metab,1994,79(6):1605-1608.
  • 5Gendrel D,Bohunon C.Procalcitonin in pediatrics for differentiation of bacterial and viral infections[J].Intensive Care Med,2000,26(Suppl 2):S178-181.
  • 6Fazakas J,Gondos T,Varga M.Analysis of systemic and regionalprocalcitonin serum levels during liver transplantation[J].Transpl Int,2003,16(7):465-470.
  • 7陈灏珠.实用内科学[M].北京:人民卫生出版社,2004.2426.
  • 8全国第十次病毒性肝炎及肝病学术会议.病毒性肝炎及肝病的诊断标准[J].中华传染病杂志,2001,19(1):53.
  • 9李显勇,夏刚.自发性腹膜炎对慢性肝衰竭预后的影响.实用肝病杂志,2010,13(10):375-376.
  • 10Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J].Lancet Infect Dis, 2013,31(12): S1473-3099.

共引文献70

同被引文献19

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部